66746 Results

People

  1. Brennan
    Brennan
  2. Gonen
    Gonen
  3. Vickers
    Vickers
  4. Ladanyi
    Ladanyi
  5. Scher
    Scher
  6. Motzer
    Motzer
  7. Reuter
    Reuter
  8. Jarnagin
    Jarnagin
  9. Fong
    Fong
  10. Antonescu
    Antonescu

Groups

  1. Department of Medicine (19346)
  2. GSK Faculty (13834)
  3. Surgery (13274)
  4. Sloan Kettering Institute Faculty (11206)
  5. Solid Tumor Oncology Division (10830)
  6. Survivorship Research (8899)
  7. Sloan Kettering Institute Postdocs (7820)
  8. Population Sciences Research Program (7144)
  9. Department of Pathology and Laboratory Medicine (6438)
  10. Epidemiology and Biostatistics (6429)
  1. "Journal article"
Formats
  1. Journal Article (66746)
Groups
  1. Department of Medicine (19346)
  2. GSK Faculty (13834)
  3. Surgery (13274)
  4. Sloan Kettering Institute Faculty (11206)
  5. Solid Tumor Oncology Division (10830)
  6. Survivorship Research (8899)

More Groups

People
  1. Murray Brennan (769)
  2. Mithat Gonen (757)
  3. Andrew Vickers (683)
  4. Marc Ladanyi (647)
  5. Howard Scher (624)
  6. Robert Motzer (609)

More People

Years
  1. 2025 (1026)
  2. 2024 (2329)
  3. 2023 (2318)
  4. 2022 (2449)
  5. 2021 (2507)
  6. 2020 (2337)

More Years

Publications
  1. Journal of Clinical Oncology (2143)
  2. Cancer (1294)
  3. Clinical Cancer Research (1174)
  4. Proceedings of the National Academy of Sciences of the United States of America (985)
  5. Blood (938)
  6. Annals of Surgical Oncology (885)

More Publications

Publishers
  1. Elsevier Inc. (7387)
  2. Springer (4153)
  3. Elsevier Science, Inc. (3901)
  4. Lippincott Williams & Wilkins (3828)
  5. Nature Publishing Group (3746)
  6. Wiley Blackwell (3486)

More Publishers

Results (66746)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: A single-centre, single-arm, phase 2 trial
    Journal Article

    Taylor, J.; Mi, X.; Penson, A. V.; Paffenholz, S. V.; Alvarez, K.; Sigler, A.; Chung, S. S.; Rampal, R. K.; Park, J. H.; Stein, E. M.; more...
    The Lancet Haematology (2020)

    Fulltext@MSK | Save
  • Prespecified 4-kallikrein marker model at age 50 or 60 for early detection of lethal prostate cancer in a large population based cohort of asymptomatic men followed for 20 years
    Journal Article

    Vertosick, E. A.; Häggström, C.; Sjoberg, D. D.; Hallmans, G.; Johansson, R.; Vickers, A. J.; Stattin, P.; Lilja, H.
    Journal of Urology (2020)

    Fulltext@MSK | Save
  • Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): Results from a randomised, multicentre, open-label, phase 3 study
    Journal Article

    Dimopoulos, M.; Quach, H.; Mateos, M. V.; Landgren, O.; Leleu, X.; Siegel, D.; Weisel, K.; Yang, H.; Klippel, Z.; Zahlten-Kumeli, A.; more...
    Lancet (2020)

    Fulltext@MSK | Save
  • Evaluating the impact of penile girth discrepancy on patient bother in men with Peyronie's disease: An observational study
    Journal Article

    Salter, C. A.; Nascimento, B.; Terrier, J. E.; Taniguchi, H.; Bernie, H.; Miranda, E.; Jenkins, L.; Schofield, E.; Mulhall, J. P.
    Journal of Sexual Medicine (2020)

    Fulltext@MSK | Save
  • A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013
    Journal Article

    Wong, S. F.; Unger, J. M.; Wade, J. L. 3rd; Wagner, L. I.; Lacouture, M. E.; Humphries, K. C.; Moseley, A.; Arnold, K.; Velasco, M. R. Jr; Floyd, J. D.; more...
    Journal of Patient-Reported Outcomes (2020)

    Fulltext@MSK | Save
  • Imaging resident and recruited macrophage contribution to Wallerian degeneration
    Journal Article

    Boissonnas, A.; Louboutin, F.; Laviron, M.; Loyher, P. L.; Reboussin, E.; Barthelemy, S.; Réaux-Le Goazigo, A.; Lobsiger, C. S.; Combadière, B.; Mélik Parsadaniantz, S.; more...
    Journal of Experimental Medicine (2020)

    Fulltext@MSK | Save
  • Cutting edge: STAT1-mediated epigenetic control of Rsad2 promotes clonal expansion of antiviral NK cells
    Journal Article

    Wiedemann, G. M.; Geary, C. D.; Lau, C. M.; Sun, J. C.
    Journal of Immunology (2020)

    Fulltext@MSK | Save
  • Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms
    Journal Article

    Harrington, K. A.; Williams, T. L.; Lawrence, S. A.; Chakraborty, J.; Al Efishat, M. A.; Attiyeh, M. A.; Askan, G.; Chou, Y.; Pulvirenti, A.; McIntyre, C. A.; more...
    Journal of Medical Imaging (2020)

    Fulltext@MSK | Save
  • Pembrolizumab or placebo plus etoposide and platinum as first-line therapy for extensive-stage small-cell lung cancer: Randomized, double-blind, phase III KEYNOTE-604 study
    Journal Article

    Rudin, C. M.; Awad, M. M.; Navarro, A.; Gottfried, M.; Peters, S.; Csőszi, T.; Cheema, P. K.; Rodriguez-Abreu, D.; Wollner, M.; Yang, J. C. H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • SOAT1 promotes mevalonate pathway dependency in pancreatic cancer
    Journal Article

    Oni, T. E.; Biffi, G.; Baker, L. A.; Hao, Y.; Tonelli, C.; Somerville, T. D. D.; Deschênes, A.; Belleau, P.; Hwang, C. I.; Sánchez-Rivera, F. J.; more...
    Journal of Experimental Medicine (2020)

    Fulltext@MSK | Save